IQE PLC Iqe Plc: Total Voting Rights And Block Admission Return

 
TIDMIQE 
 
 
   IQE plc 
 
   Total Voting Rights and Block Admission Return 
 
   Cardiff, UK 
 
   5 January 2021 
 
 
 
   ("IQE" or the "Company") 
 
   Total Voting Rights 
 
   As at 31 December 2020, the Company's issued share capital consisted of 
800,364,569 ordinary shares of 1 pence each ("Ordinary Shares"). All of 
these Ordinary Shares carry voting rights of one vote per Ordinary 
Share. The Company holds no Ordinary Shares in treasury. 
 
   The total number of voting rights in the Company is therefore 
800,364,569. 
 
   The above figures  may  be  used  by  shareholders as the denominator 
for the calculations by which they will determine if they are required 
to notify their interest in, or a change to their interest in, the 
Company under the Financial Conduct Authority's Disclosure Guidance and 
Transparency Rules. 
 
   Block Admission Return 
 
   The Company hereby provides an update to its block admission filed on 30 
June 2020. 
 
 
 
 
Name of company:                                                             IQE plc 
 
Name of scheme:                                                  All employee share option plan 
 
Period of return:                                               30 June 2020 to 31 December 2020 
 
Number of Ordinary Shares not issued under scheme 
 at the end of the last period:                                                               2,851,381 
 
Number of Ordinary Shares issued under scheme during 
 period:                                                                                        941,993 
 
Number of Ordinary Shares cancelled under the scheme 
 during period:                                                                                     Nil 
 
Balance of Ordinary Shares under scheme not yet issued 
 at end of period:                                                                            1,909,388 
Number and class of Ordinary Shares originally admitted   1,000,000 Ordinary Shares (4 Dec 2009) 
 under scheme and the date of admission:                   2,000,000 Ordinary Shares (11 Oct 2010) 
                                                           5,000,000 Ordinary Shares (8 Nov 2010) 
                                                           8,000,000 Ordinary Shares (5 Apr 2011) 
                                                           6,000,000 Ordinary Shares (16 May 2012) 
                                                           16,000,000 Ordinary shares (19 Jun 2012) 
                                                           8,000,000 Ordinary shares (12 Aug 2014) 
                                                           8,000,000 Ordinary shares (3 Dec 2015) 
                                                           12,000,000 Ordinary shares (20 April 2017) 
                                                           14,000,000 Ordinary shares (12 June 2018) 
                                                           12,000,000 Ordinary shares (25 January 2019) 
                                                           3,000,000 Ordinary shares (25 January 2020) 
 
 
 
 
   Contacts: 
 
   IQE plc 
 
   [phone] 
 
   Amy Barlow 
 
 
 
   Peel Hunt LLP (Nomad and Joint Broker) 
 
   [phone] 
 
   Edward Knight 
 
   Paul Gillam 
 
   Nick Prowting 
 
   Citigroup Global Markets Limited (Joint Broker) 
 
   [phone] 
 
   Christopher Wren 
 
   Peter Catterall 
 
   Headland Consultancy (Financial PR) 
 
   + 44 (0) 20 38054822 
 
   Andy Rivett-Carnac: [phone] 
 
   Chloe Francklin: [phone] 
 
   ABOUT IQE 
 
   http://iqep.com 
 
   IQE is the leading global supplier of advanced compound semiconductor 
wafers and materials solutions that enable a diverse range of 
applications across: 
 
 
   -- handset devices 
 
 
   -- global telecoms infrastructure 
 
   -- connected devices 
 
   -- 3D sensing 
 
 
   As a scaled global epitaxy wafer manufacturer, IQE is uniquely 
positioned in this market which has high barriers to entry. IQE supplies 
the whole market and is agnostic to the winners and losers at chip and 
OEM level. By leveraging the Group's intellectual property portfolio 
including know-how and patents, it produces epitaxy wafers of superior 
quality, yield and unit economics. 
 
   IQE is headquartered in Cardiff UK, with c. 650 employees across nine 
manufacturing locations in the UK, US, Taiwan and Singapore, and is 
listed on the AIM Stock Exchange in London. 
 
 
 
 

(END) Dow Jones Newswires

January 05, 2021 09:58 ET (14:58 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.